Finally, we show that, while the effect of PD-1 blockade is modest in a syngeneic AML mouse model and a humanized AML mouse model, combination PD-1/PD-1H blockade confers a synergistic antileukemia effect, leading to the regression of established AML. This evidence concerns the gene VSIR and acute myeloid leukemia.